COLLEEN FOX: Open Payments
NPI 1073225850 · FALMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,716 in 77 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,544 · 2025 $1,716
Food & beverage: $1,631Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $276 |
| Ferring Pharmaceuticals Inc. | 7 | $274 |
| Sumitomo Pharma America, Inc. | 18 | $271 |
| Endo USA, Inc. | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 2 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $78 |
| Dendreon Pharmaceuticals LLC | 3 | $71 |
| Antares Pharma, Inc. | 3 | $70 |
| 180 Medical, Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $53 |
Products named: ADSTILADRIN, ERLEADA, GEMTESA, LYNPARZA, Nubeqa, ORGOVYX, PROVENGE, XYOSTED.
Industry payments across MA — which companies pay providers there.
